These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5371696)

  • 1. Studies on flow properties of powders. 3. The influence of glidants on the technical properties of tablet granulations.
    Kristensen HG; Jensen VG
    Dan Tidsskr Farm; 1969; 43(9):205-12. PubMed ID: 5371696
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on flow properties of powders. IV. Flow properties of tablet granulations and the uniformity of tablet content.
    Kristensen HG
    Dan Tidsskr Farm; 1969; 43(9):213-9. PubMed ID: 5371697
    [No Abstract]   [Full Text] [Related]  

  • 3. Mixing of pharmaceutical powders in tablet manufacture.
    Eyjolfsson R
    Pharmazie; 2001 Jul; 56(7):590-1. PubMed ID: 11487984
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of various wet granulation procedures on the technological characteristics of powders and tablets].
    Crimella T; Delucchi F; Gallazzi A; Kauten G; Iamartino P; Maccario G; Pedrani M; Rizzo D
    Boll Chim Farm; 1984 May; 123(5):210-22. PubMed ID: 6487424
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of surface color as an expedient QC method for the detection of deviations in tablet hardness.
    Siddiqui A; Nazzal S
    Int J Pharm; 2007 Aug; 341(1-2):173-80. PubMed ID: 17499947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pharmaceutical technology of tablet making. Physical processes taking place during tablet formation and the effect of pressure on properties of the tablets].
    Moldenhauer H; Kala H; Zessin G; Dittgen M
    Pharmazie; 1980; 35(11):714-26. PubMed ID: 7465618
    [No Abstract]   [Full Text] [Related]  

  • 8. [Technologic control of tablet coatings].
    Dia S; Guyot JC; Traisnel M
    J Pharm Belg; 1973; 28(6):663-80. PubMed ID: 4774837
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent advances in tablet technology.
    Cooper J
    Adv Pharm Sci; 1971; 3():1-106. PubMed ID: 4947390
    [No Abstract]   [Full Text] [Related]  

  • 10. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example.
    Sun CC
    Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the morphogranulometry and hydrophobicity of talc on its antisticking power in the production of tablets.
    Leterme P; Gayot A; Finet G; Bizi M; Flament MP
    Int J Pharm; 2005 Jan; 289(1-2):109-15. PubMed ID: 15652204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on tablets. XVIII. Preparation of basic granulates for tablets by pulverization].
    Malý J; Rak J
    Cesk Farm; 1968 Mar; 17(3):122-6. PubMed ID: 5666302
    [No Abstract]   [Full Text] [Related]  

  • 13. Wiener bounds for complex permittivity in terahertz spectroscopy: case study of two-phase pharmaceutical tablets.
    Tuononen H; Fukunaga K; Kuosmanen M; Ketolainen J; Peiponen KE
    Appl Spectrosc; 2010 Jan; 64(1):127-31. PubMed ID: 20132608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: A torque arm mixer for studying wet massing.
    Travers DN; Rogerson AG; Jones TM
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():3P. PubMed ID: 2703
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of flow promoting agents on the flow properties of mixtures of powders and on the physical properties of the resulting tablets.
    Lubner GC; Ricciardiello G
    Boll Chim Farm; 1977 Jan; 116(1):40-52. PubMed ID: 192253
    [No Abstract]   [Full Text] [Related]  

  • 16. The presence of microorganisms in some common excipients used in tablet formulation.
    Obuekwe IF; Eichie F
    Acta Pol Pharm; 2006; 63(2):121-5. PubMed ID: 17514875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Technical and present therapeutic aspects of tablet manufacture].
    Jaminet F
    Pharm Acta Helv; 1968 Mar; 43(3):129-52. PubMed ID: 4888486
    [No Abstract]   [Full Text] [Related]  

  • 18. [Microcrystalline cellulose and their flow -- morphological properties modifications as an effective excpients in tablet formulation technology containing lattice established API and also dry plant extract].
    Zgoda MM; Nachajski MJ; Kołodziejczyk MK
    Polim Med; 2009; 39(1):17-30. PubMed ID: 19580170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some studies of the effect of processing variables on the properties of granules and tablets made by wet granulation.
    Ghanta SR; Srinivas R; Rhodes CT
    Pharm Acta Helv; 1986; 61(7):191-7. PubMed ID: 3737619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.